Related Experiment Video
Updated: May 28, 2026
06:01
Modulating Shape of Polyester Based Polymersomes using Osmotic Pressure
Published on: April 21, 2021
Polymersomes for drug delivery: design, formation and characterization.
1Department of Polymer Chemistry and Biomaterials, Institute for Biomedical Technology and Technical Medicine, MIRA, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.
Summary
Polymersomes (Ps) are advanced drug delivery systems offering stability and tunable properties. This review highlights their recent progress, preparation, and applications in medicine.
Area of Science:
- Nanotechnology
- Materials Science
- Biomedical Engineering
Background:
- Polymersomes (Ps) have emerged as versatile carriers due to their colloidal stability and tunable membrane properties.
- The use of poly(ethylene glycol) (PEG) in block copolymers enhances blood circulation times for Ps.
- Ps find applications in drug delivery, medical imaging, electronics, and nanoreactors.
Purpose of the Study:
- To review recent advances in polymersomes as drug delivery systems.
- To discuss critical factors influencing polymersome formation.
- To address preparative methods, characterization, and biological interactions of polymersomes.
Main Methods:
- Review of literature on polymersome synthesis and characterization.
- Analysis of factors affecting polymersome formation and stability.
- Evaluation of protein and cell interactions, in vivo kinetics, and biodistribution.
Main Results:
- Polymersomes offer tunable properties for encapsulating diverse drugs and molecules.
- Biodegradable and stimuli-sensitive polymersomes show great promise for targeted applications.
- PEGylated polymersomes exhibit prolonged circulation times, beneficial for drug delivery.
Conclusions:
- Polymersomes represent a significant advancement in nanocarrier technology for drug delivery.
- Understanding formation parameters and biological interactions is crucial for optimizing Ps efficacy.
- Further research into stimuli-responsive polymersomes will expand their therapeutic potential.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...